<- Go Home
RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. The company offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; and machine learning and liver ablation solutions. It has collaboration with Vision RT for integration of MapRT with RayStation treatment planning system. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
Market Cap
SEK 7.7B
Volume
139.0K
Cash and Equivalents
SEK 407.3M
EBITDA
SEK 359.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
SEK 1.2B
Profit Margin
92.42%
52 Week High
SEK 373.50
52 Week Low
SEK 166.80
Dividend
1.79%
Price / Book Value
7.79
Price / Earnings
33.71
Price / Tangible Book Value
18.00
Enterprise Value
SEK 7.7B
Enterprise Value / EBITDA
17.71
Operating Income
SEK 329.6M
Return on Equity
24.47%
Return on Assets
10.09
Cash and Short Term Investments
SEK 407.3M
Debt
SEK 394.8M
Equity
SEK 985.3M
Revenue
SEK 1.3B
Unlevered FCF
SEK 93.4M
Sector
Health Care Technology
Category
N/A